AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34433306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive assessment after randomization but before assigned treatment, using a cognitive battery developed in the REGARDS Study.
Number of subjects: 1000
Study 35633025 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 300 mg subcutaneously once a month
Number of subjects: 164
Study 34076688 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 8
Study 34076688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 35447353 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous training
Number of subjects: 105
Study 35447353 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training
Number of subjects: 105
Study 35447353 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study 34135038 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE)
Number of subjects: 150
Study 34135038 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (Mediterranean diet nutritional counselling)
Number of subjects: 150
Study 32664127 — intervention group
Group type: EXPERIMENTAL
Intervention: VieScope
Number of subjects: 55
Study 35022943 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent coaching (PC) intervention for 24 weeks
Number of subjects: 49
Study 35022943 — intervention group
Group type: COMPARATOR
Intervention: Enhanced community treatment (ECT)
Number of subjects: 49
Study 32303210 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nystatin (1 ml three times a day)
Number of subjects: 95
Study 32303210 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (1 ml three times a day)
Number of subjects: 95
Study 34636112 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptacog beta (EB) at doses of 75 or 225 μg/kg for bleeding episodes and 75 μg/kg or 200 μg/kg for perioperative care.
Number of subjects: 60
Study 34636112 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptacog beta (EB) for perioperative care (75 μg/kg for minor procedures, 200 μg/kg for major surgeries).
Number of subjects: 60
Study 32371513 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive health profiles including assessments of physical health, cognitive functioning, emotional state, social connectedness, quality of life, and more.
Number of subjects: 1000
Study 33065651 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel Node Biopsy (SNB) only
Number of subjects: 353
Study 33065651 — intervention group
Group type: COMPARATOR
Intervention: Sentinel Node Biopsy + Axillary Dissection (SNB + AD)
Number of subjects: 353
Study 34071782 — intervention group
Group type: EXPERIMENTAL
Intervention: Online health application supported by a mobile telephone or tablet (mHealth)
Number of subjects: 240
Study 34071782 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study 2010124724 — intervention group
Group type: EXPERIMENTAL
Intervention: parecoxib-sodium 40 mg intravenously after operation
Number of subjects: 60
Study 35500381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented brown rice beverage (BA)
Number of subjects: 40
Study 35500381 — intervention group
Group type: COMPARATOR
Intervention: Fermented white rice beverage (WA)
Number of subjects: 40
Study 32322017 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldmann Applanation Tonometry (GAT) by ophthalmologists
Number of subjects: 116
Study 32322017 — intervention group
Group type: COMPARATOR
Intervention: Goldmann Applanation Tonometry (GAT) by nurses
Number of subjects: 116
Study 32322017 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA)
Number of subjects: 116
Study 33454249 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomographic angiography (CCTA)
Number of subjects: 1728
Study 33454249 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA with a threshold of ≥70% diameter stenosis (DS)
Number of subjects: 1728
Study 33454249 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA of good-to-excellent quality
Number of subjects: 1728
Study 32487982 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (walking and/or running, 3 to 5 days/week)
Number of subjects: 75
Study 32487982 — intervention group
Group type: COMPARATOR
Intervention: Stretching (1 day/week)
Number of subjects: 75
Study 35016998 — intervention group
Group type: EXPERIMENTAL
Intervention: Raspberry consumption (280 g/d for 8 weeks)
Number of subjects: 24
Study 33932704 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity aerobic exercise (forced or voluntary modalities)
Number of subjects: 0
Study 32272517 — intervention group
Group type: EXPERIMENTAL
Intervention: INhance Post‐Injection Serum with TriHex Technology®
Number of subjects: 0
Study 32272517 — intervention group
Group type: COMPARATOR
Intervention: Bland moisturizer
Number of subjects: 0
Study 36468408 — intervention group
Group type: COMPARATOR
Intervention: Improved Alc‐IT (n=79)
Number of subjects: 242
Study 36468408 — intervention group
Group type: COMPARATOR
Intervention: Standard Alc‐IT (n=84)
Number of subjects: 242
Study 36468408 — intervention group
Group type: COMPARATOR
Intervention: Control (unspecific inhibition training, n=79)
Number of subjects: 242
Study 33546039 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 0
Study 33546039 — intervention group
Group type: COMPARATOR
Intervention: Medication treatment
Number of subjects: 0
Study 32138961 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloons (DCB)
Number of subjects: 4590
Study 34645402 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent school-based intervention (teacher training, education curriculum, environmental improvements)
Number of subjects: 921
Study 35177255 — intervention group
Group type: EXPERIMENTAL
Intervention: OM85
Number of subjects: 0
Study 35177255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34196582 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT implementation
Number of subjects: 20
Study 35943946 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Training (ACT) program
Number of subjects: 143
Study 35943946 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 143
Study 34551918 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release metformin 3 g daily
Number of subjects: 180
Study 34551918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 35011603 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention
Number of subjects: 577
Study 35011603 — intervention group
Group type: COMPARATOR
Intervention: Prompt infertility management (Control)
Number of subjects: 577
Study 32602557 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (group A)
Number of subjects: 62
Study 32602557 — intervention group
Group type: COMPARATOR
Intervention: No physical therapy (group B)
Number of subjects: 62
Study 34791943 — intervention group
Group type: EXPERIMENTAL
Intervention: FLAIR‐rSI (Fluid-attenuated inversion recovery relative signal intensity) quantified in stroke lesions
Number of subjects: 813
Study 34791943 — intervention group
Group type: EXPERIMENTAL
Intervention: Median times of last seen well
Number of subjects: 813
Study 34791943 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom recognition
Number of subjects: 813
Study 34791943 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated median stroke onset based on FLAIR‐rSI profiles
Number of subjects: 813
Study 34169500 — intervention group
Group type: EXPERIMENTAL
Intervention: p-value threshold of 0.005
Number of subjects: 202
Study 34169500 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 202
Study 36181273 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing of sheath of peroneal tendons to the calcaneal plate using ethibond suture in a figure‐of‐8 shape.
Number of subjects: 33
Study 36181273 — intervention group
Group type: COMPARATOR
Intervention: Control group of 12 surgically treated calcaneal fractures without PTI.
Number of subjects: 33
Study 33653766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led antimicrobial stewardship (AMS) programme
Number of subjects: 12
Study 32883212 — intervention group
Group type: EXPERIMENTAL
Intervention: D-optimal blocking procedure for allocation to study arms
Number of subjects: 162
Study 32883212 — intervention group
Group type: COMPARATOR
Intervention: Unstratified random allocation
Number of subjects: 162
Study 32883212 — intervention group
Group type: COMPARATOR
Intervention: Stratified random allocation by first-visit group
Number of subjects: 162
Study 34211327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant limb intervention (4-repetitions of 5-seconds knee extension maximal voluntary isometric contractions: MVIC)
Number of subjects: 32
Study 34211327 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-dominant limb intervention (4-repetitions of 5-seconds knee extension maximal voluntary isometric contractions: MVIC)
Number of subjects: 32
Study 34211327 — intervention group
Group type: COMPARATOR
Intervention: Control (no conditioning exercise)
Number of subjects: 32
Study 34211327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-test dominant leg MVIC F100 forces
Number of subjects: 32
Study 34211327 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-test and post-10 min dominant leg MVIC F100 forces
Number of subjects: 32
Study 32337229 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoles with a toe-grip bar
Number of subjects: 52
Study 32337229 — intervention group
Group type: COMPARATOR
Intervention: Regular insoles without a toe-grip bar
Number of subjects: 52
Study 34232900 — intervention group
Group type: EXPERIMENTAL
Intervention: FTRPS measure for guilty group
Number of subjects: 30
Study 34232900 — intervention group
Group type: COMPARATOR
Intervention: FTRPS measure for innocent group
Number of subjects: 30
Study 34232900 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Fingerprinting Graphs (BFG) on delta, theta, alpha, and beta bands
Number of subjects: 30
Study 34736525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive management (treatment to induce remission)
Number of subjects: 0
Study 34736525 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (anxiety, depression, health perceptions)
Number of subjects: 0
Study 32391894 — intervention group
Group type: EXPERIMENTAL
Intervention: Disney movies during chemotherapy
Number of subjects: 50
Study 36401084 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE Inhibitors (ACEi)
Number of subjects: 133
Study 36401084 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin Receptor Blockers (ARB)
Number of subjects: 133
Study 36401084 — intervention group
Group type: COMPARATOR
Intervention: Neither ACEi nor ARB
Number of subjects: 133
Study 32580701 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing staff in dementia special care units, larger nursing homes, and nursing homes located in suburban/urban municipalities.
Number of subjects: 3693
Study 32580701 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing staff overall
Number of subjects: 3693
Study 34416898 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular injection of cell-free stem cell-derived extract (CCM)
Number of subjects: 12
Study 32967871 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels measured by the Physical Activity Unit 7-item Screener
Number of subjects: 4508
Study 32967871 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometers worn by a representative subsample (10% of participants) for 9 days
Number of subjects: 4508
Study 32967871 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated questionnaires for adherence to the Mediterranean diet, quality of life, sleep duration, PA and sedentary behaviour
Number of subjects: 4508
Study 35527596 — intervention group
Group type: EXPERIMENTAL
Intervention: Care manager support
Number of subjects: 269
Study 35527596 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 269
Study 33985404 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-delivered counseling intervention
Number of subjects: 69
Study 33985404 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 69
Study 33879394 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified surgical technique (group 2)
Number of subjects: 415
Study 33879394 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical technique (group 1)
Number of subjects: 415
Study 32978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-Based Graduated Walking Program (HBGWP)
Number of subjects: 54
Study 32978102 — intervention group
Group type: COMPARATOR
Intervention: Fixed walking recommendation
Number of subjects: 54
Study 32978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (HBGWP and fixed recommendation)
Number of subjects: 54
Study 32978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing walking over time
Number of subjects: 54
Study 33745379 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled regional analgesia (PCRA)
Number of subjects: 134
Study 33745379 — intervention group
Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (IV-PCA)
Number of subjects: 134
Study 32471106 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: 10,000 IU/day for eight weeks followed by 1000 IU/day for four weeks
Number of subjects: 0
Study 32471106 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: 50,000 IU/week for 12 weeks
Number of subjects: 0
Study 32471106 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: 100,000 IU/every other week for 12 weeks
Number of subjects: 0
Study 32471106 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 35382631 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) for 12 weeks
Number of subjects: 50
Study 35382631 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 50
Study 33550841 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational HIV/STI prevention intervention
Number of subjects: 108
Study 34911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Salutogenic approach-based interviews
Number of subjects: 49
Study 32363648 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet addiction
Number of subjects: 0
Study 32363648 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone addiction
Number of subjects: 0
Study 34096759 — intervention group
Group type: EXPERIMENTAL
Intervention: Domain-specific Episodic Future Thinking (DS-EFT)
Number of subjects: 90
Study 34096759 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 90
Study 34096759 — intervention group
Group type: COMPARATOR
Intervention: Episodic Recent Thinking (ERT)
Number of subjects: 90
Study 33867308 — intervention group
Group type: EXPERIMENTAL
Intervention: iPhone use with Night Shift enabled
Number of subjects: 167
Study 33867308 — intervention group
Group type: EXPERIMENTAL
Intervention: iPhone use with Night Shift disabled
Number of subjects: 167
Study 33867308 — intervention group
Group type: COMPARATOR
Intervention: No phone use
Number of subjects: 167
Study 34633464 — intervention group
Group type: EXPERIMENTAL
Intervention: High-status model video
Number of subjects: 0
Study 34633464 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-status model video
Number of subjects: 0
Study 34633464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 0
Study 32960007 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol combined with budesonide
Number of subjects: 98
Study 32960007 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 98
Study 33009245 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario‐Tailored Opioid Messaging Program (STOMP)
Number of subjects: 604
Study 33009245 — intervention group
Group type: COMPARATOR
Intervention: Routine instruction (Control)
Number of subjects: 604
Study 32182336 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warnings on sugar-sweetened beverages (SSBs)
Number of subjects: 400
Study 35585944 — intervention group
Group type: EXPERIMENTAL
Intervention: Articaine and adrenaline combined with a computer‐controlled anesthesia system
Number of subjects: 100
Study 35585944 — intervention group
Group type: COMPARATOR
Intervention: Articaine and adrenaline anesthesia
Number of subjects: 100
Study 34670754 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with additional milk, yoghurt, and cheese providing 562 (166) mg/day calcium and 12 (6) g/day protein, achieving a total intake of 1142 (353) mg calcium/day and 69 (15) g/day protein (1.1 g/kg body weight)
Number of subjects: 7195
Study 34670754 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with additional milk, yoghurt, and cheese
Number of subjects: 7195
Study 34670754 — intervention group
Group type: COMPARATOR
Intervention: Usual menus in control facilities
Number of subjects: 7195
Study 32358697 — intervention group
Group type: EXPERIMENTAL
Intervention: schoolMAX intervention
Number of subjects: 103
Study 32358697 — intervention group
Group type: COMPARATOR
Intervention: services‐as‐usual (SAU)
Number of subjects: 103
Study 36332454 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone symptom triage protocol (TeleTRIAGE)
Number of subjects: 65
Study 36332454 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing care
Number of subjects: 65
Study 32970095 — intervention group
Group type: EXPERIMENTAL
Intervention: GWAS analysis in UKB cohort
Number of subjects: 172995
Study 32970095 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 172995
Study 33641545 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes empowerment
Number of subjects: 131
Study 33641545 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes distress
Number of subjects: 131
Study 33641545 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 131
Study 33641545 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction effect of depression on diabetes distress and mastery
Number of subjects: 131
Study 33642051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lockdown (social distancing measures)
Number of subjects: 100
Study 33008621 — intervention group
Group type: EXPERIMENTAL
Intervention: Broken Circle (BC) method
Number of subjects: 256
Study 33008621 — intervention group
Group type: EXPERIMENTAL
Intervention: BC method (post-test)
Number of subjects: 256
Study 35068330 — intervention group
Group type: EXPERIMENTAL
Intervention: Krocina™ (15 mg twice a day for six weeks)
Number of subjects: 72
Study 35068330 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same coating as Krocina™)
Number of subjects: 72
Study 33719578 — intervention group
Group type: EXPERIMENTAL
Intervention: Research conducted in women
Number of subjects: 3
Study 33719578 — intervention group
Group type: COMPARATOR
Intervention: Research conducted in men
Number of subjects: 3
Study 32375491 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led Activate intervention (four behaviour change consultations over 3 months)
Number of subjects: 195
Study 32375491 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led Activate intervention
Number of subjects: 195
Study 34243211 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-cranking training with EMS (A+EMS)
Number of subjects: 25
Study 34243211 — intervention group
Group type: COMPARATOR
Intervention: Arm-cranking training without EMS (A)
Number of subjects: 25
Study 33043475 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical device (digital technology comprising an EAI smart case connected to a mobile APP)
Number of subjects: 100
Study 32516744 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week home-based exercise program
Number of subjects: 110
Study 32516744 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 110
Study 35708696 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide monotherapy (160 mg for 1 year)
Number of subjects: 227
Study 36108484 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation condition (belt speed ratio 1:3)
Number of subjects: 15
Study 36108484 — intervention group
Group type: COMPARATOR
Intervention: Baseline condition (belt speed ratio 1:1)
Number of subjects: 15
Study 33197285 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexidartinib (1000 mg/d for phase 1 extension study; 1000 mg/d for 2 weeks then 800 mg/d for ENLIVEN; 800 mg/d for crossover patients)
Number of subjects: 130
Study 33197285 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 130
Study 33731516 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep rate mode
Number of subjects: 9
Study 32663998 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Internet intervention (Deprexis)
Number of subjects: 340
Study 32663998 — intervention group
Group type: COMPARATOR
Intervention: Standard psychotherapy
Number of subjects: 340
Study 35654660 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMBRE intervention
Number of subjects: 424
Study 35654660 — intervention group
Group type: COMPARATOR
Intervention: Minimal-intensity intervention
Number of subjects: 424
Study 32446260 — intervention group
Group type: EXPERIMENTAL
Intervention: Shirodkar cerclage
Number of subjects: 350
Study 32446260 — intervention group
Group type: COMPARATOR
Intervention: Control group (17-OH-progesterone treatment without cerclage)
Number of subjects: 350
Study 32484534 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP-guided antibiotic treatment duration (n=170)
Number of subjects: 504
Study 32484534 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day fixed antibiotic treatment duration (n=169)
Number of subjects: 504
Study 32484534 — intervention group
Group type: COMPARATOR
Intervention: 14-day fixed antibiotic treatment duration (n=165)
Number of subjects: 504
Study 36170304 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (residual bone height < 3 mm)
Number of subjects: 87
Study 36170304 — intervention group
Group type: COMPARATOR
Intervention: Control group (residual bone height ≥ 3 mm)
Number of subjects: 87
Study 34348323 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray for 3 weeks followed by surgical intervention for 3 months
Number of subjects: 31